Twist Bioscience Corporation

NasdaqGS:TWST Voorraadrapport

Marktkapitalisatie: US$2.4b

Twist Bioscience Beheer

Beheer criteriumcontroles 3/4

Twist Bioscience's CEO is Emily Leproust, appointed in Apr 2013, has a tenure of 11.58 years. total yearly compensation is $8.00M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth $10.23M. The average tenure of the management team and the board of directors is 3.5 years and 8 years respectively.

Belangrijke informatie

Emily Leproust

Algemeen directeur

US$8.0m

Totale compensatie

Percentage CEO-salaris8.6%
Dienstverband CEO11.6yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn3.5yrs
Gemiddelde ambtstermijn bestuur8yrs

Recente managementupdates

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Recent updates

Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business

Sep 25
Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business

Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues

Aug 20
Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues

Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)

Aug 04

Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock

Jul 26

We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Jun 10
We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

May 04
Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

Twist Bioscience: NGS Is Taking Off

May 03

Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Twist Bioscience: Strong Performance In A Soft Market

Feb 07

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Jan 22
We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Dec 18
Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

Oct 05
Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Jul 07
We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Analyse CEO-vergoeding

Hoe is Emily Leproust's beloning veranderd ten opzichte van Twist Bioscience's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$192m

Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Jun 30 2019n/an/a

-US$96m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018n/an/a

-US$77m

Sep 30 2018US$525kUS$362k

-US$71m

Compensatie versus markt: Emily's total compensation ($USD8.00M) is about average for companies of similar size in the US market ($USD6.66M).

Compensatie versus inkomsten: Emily's compensation has increased whilst the company is unprofitable.

CEO

Emily Leproust (51 yo)

11.6yrs

Tenure

US$7,998,637

Compensatie

Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Emily Leproust
Co-Founder11.6yrsUS$8.00m0.42%
$ 10.2m
Patrick Finn
President & COO2.1yrsUS$5.23m0.099%
$ 2.4m
Paula Green
Senior Vice President of Human Resources8.7yrsUS$2.49m0.045%
$ 1.1m
William Banyai
Senior VP of Advanced Development4.8yrsUS$2.82m0.44%
$ 10.7m
Adam Laponis
Chief Financial Officerless than a yeargeen gegevens0.0042%
$ 101.1k
Robert Werner
VP & Chief Accounting Officer1.5yrsgeen gegevens0.012%
$ 297.1k
Siyuan Chen
Chief Technology Officer3.8yrsgeen gegevensgeen gegevens
Aaron Sato
Chief Scientific Officer3.8yrsgeen gegevensgeen gegevens
Michael Fero
Chief Information Officerless than a yeargeen gegevensgeen gegevens
Dennis Cho
Senior VP3.2yrsUS$1.96m0.058%
$ 1.4m
Angela Bitting
Chief ESG Officer & Senior VP of Corporate Affairs3.8yrsgeen gegevensgeen gegevens
Mark Buck
Senior Vice President of Operations1.1yrsgeen gegevensgeen gegevens

3.5yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: TWST's management team is considered experienced (3.5 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Emily Leproust
Co-Founder11.6yrsUS$8.00m0.42%
$ 10.2m
William Banyai
Senior VP of Advanced Development11.6yrsUS$2.82m0.44%
$ 10.7m
Keith Crandell
Independent Director11.1yrsUS$272.49k0.16%
$ 3.9m
Robert Chess
Lead Independent Director10.3yrsUS$303.98k0.11%
$ 2.7m
Nelson Chan
Independent Director5.5yrsUS$284.99k0.030%
$ 742.8k
Robert Ragusa
Independent Director8yrsUS$271.34k0.023%
$ 565.5k
Jan Johannessen
Independent Director6.1yrsUS$284.99k0.020%
$ 482.9k
Melissa Starovasnik
Independent Director3.3yrsUS$276.61k0.019%
$ 452.5k
Xiaoying Mai
Independent Director6.3yrsUS$269.99k0.043%
$ 1.0m

8.0yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: TWST's board of directors are considered experienced (8 years average tenure).